View All Upcoming Sponsored Webinars
July 29, 201511 am to 12 pm EDT
Protein biomarkers provide insights into the safety, efficacy and target population for drugs in development. Typically, immunoassays have a lower limit of quantitation (LLOQ) in the 1-10 pm / mL range, and our ability to routinely and robustly measure biomarker levels below that range means that potentially valuable protein biomarker signatures go undetected and unused. The Singulex® Erenna® platform uses a digital ELISA approach that can detect proteins down to the femtogram / mL levels, providing an unprecedented opportunity to utilize ultra-low biomarker concentrations in clinical development. We describe the application of ultrasensitive immunoassays during drug development and present as a case study the development and implementation of assays to Ab42 and IL17F in human plasma. Challenges encountered and approaches taken in the development of the methods will be discussed, as well as comparison of the performance of these assays to corresponding ELISA methods.
You will benefit from attending this event if you are a vice president, director, or manager of a pharmaceutical or biotech company with responsibilities in the following areas:
John Kamerud, PhD.
Eurofins Pharma Bioanalytical Services
Dr. Kamerud is Scientific Director at Eurofins’ St Charles, Missouri site, where his role is to serve as scientific and technical advisor for both clients and internal teams for development, validation, and application of assays to comply with scientific goals and regulatory requirements. He received his PhD (Biochemistry) degree in 1987 from the University of Minnesota. Dr Kamerud has over 20 years of experience in the development, validation and implementation of immunoassay methods, holding positions with EMD Millipore, Covance Laboratories and Eli Lilly and Company.
250 First Avenue, Suite 300
Needham, MA 02494
Biological Therapeutic Products
Biomarkers & Diagnostics
Bioprocess & Manufacturing
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
IT & Informatics
Technology & Tools For Life Science
Cambridge Healthtech Institute
Cambridge Innovation Institute